Deborah Cohen1. Show Affiliations » 1. The BMJ.
Abstract
Entities: Chemical Disease
Mesh: See more » Angiogenesis Inhibitors/administration & dosageAntibodies, Monoclonal, Humanized/administration & dosageBevacizumabEthics, MedicalHumansMacular Degeneration/drug therapyOff-Label Use/ethicsOff-Label Use/legislation & jurisprudencePractice Patterns, Physicians'/ethicsPractice Patterns, Physicians'/standardsPractice Patterns, Physicians'/statistics & numerical dataPractice Patterns, Physicians'/trendsRanibizumabTreatment OutcomeTruth Disclosure/ethicsUnited Kingdom
Substances: See more » Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedBevacizumabRanibizumab
Year: 2015 PMID: 25869865 DOI: 10.1136/bmj.h1981
Source DB: PubMed Journal: BMJ ISSN: 0959-8138